Corcept Therapeutics Incorporated · NASDAQ:CORT
Lyon Joseph Douglas sold 10,000 Corcept Therapeutics Incorporated shares (Form 4)
Traded Oct 1 to Oct 2, 2026 · Filed Oct 5, 2026
From Oct 1 to Oct 2, 2026, Lyon Joseph Douglas (See Remarks) sold 10,000 Corcept Therapeutics Incorporated shares at an average US$116.07 for US$1.16M under a trading plan, leaving 5,683 shares. Filed Oct 5, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$116.07 average (US$115.40 to US$116.54)
- Value
- US$1.16M
- Holding after
- 5,683 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock | Option exercise | 810 | US$13.56 | 6,493 | Direct |
| Oct 1, 2026 | Common Stock | Sale | 810 | US$115.40 | 5,683 | Direct |
| Oct 2, 2026 | Common Stock | Option exercise | 3,357 | US$13.56 | 9,040 | Direct |
| Oct 2, 2026 | Common Stock | Option exercise | 5,833 | US$19.26 | 14,873 | Direct |
| Oct 2, 2026 | Common Stock | Sale | 4,446 | US$115.70 | 10,427 | Direct |
| Oct 2, 2026 | Common Stock | Sale | 4,744 | US$116.54 | 5,683 | Direct |
Source
Related
- Corcept Therapeutics Incorporated
- Lyon Joseph Douglas
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Lyon Joseph Douglas · Sep 16, 2026
- Form 4 · Lyon Joseph Douglas · Sep 3, 2026
- Form 4 · Lyon Joseph Douglas · Aug 5, 2026
- Form 4 · Lyon Joseph Douglas · Jun 3, 2026
- Form 4 · Lyon Joseph Douglas · May 29, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026
- Form 4 · Robb Gary Charles · Sep 18, 2026